Harry Reid Invokes Nazi Germany to Make Case for Syria

First vote scheduled for Wednesday.

Senate Majority Leader Harry Reid, D-Nev., speaks to reporters after the Senate stepped back from the brink of a political meltdown, clearing the way for confirmation of one of President Barack Obama's long-stalled nominations, at the Capitol in Washington, Tuesday, July 16, 2013. 
National Journal
Shane Goldmacher
Add to Briefcase
Shane Goldmacher
Sept. 9, 2013, 10:47 a.m.

Sen­ate Ma­jor­ity Lead­er Harry Re­id, D-Nev., in­voked the killings in Nazi Ger­many in World War II on Monday as he opened de­bate on a meas­ure to au­thor­ize mil­it­ary strikes against Syr­ia.

“This bru­tal­ity de­mands a re­sponse,” Re­id said, an­noun­cing the first key pro­ced­ur­al vote will come on Wed­nes­day.

Re­id said the United States had to en­force in­ter­na­tion­al pro­hib­i­tions against the use of such weaponry that have been in place for a cen­tury, since World War I, be­cause of the grue­some nature of deadly chem­ic­als. He said he had re­cently watched a 13-minute video of the chem­ic­al at­tacks in Syr­ia, as vic­tims writhed in pain. “I will nev­er get that out of my mind,” he said.

While Re­id said he un­der­stood that oth­ers in the Sen­ate dis­agreed with in­ter­ven­ing mil­it­ar­ily, he had harsh words for stand­ing by. “Sit­ting on the side­lines won’t make us a bet­ter na­tion to­mor­row,” he said. Amer­ica, he said, had to re­mem­ber the les­sons of World War II and, spe­cific­ally, Aus­chwitz, the Nazi-run con­cen­tra­tion camp.

He read — twice — a quote he at­trib­uted to Dante: “The hot­test places in hell are re­served for those who in times of great mor­al crisis main­tain their neut­ral­ity.”

Typ­ic­ally, Sen­ate Minor­ity Lead­er Mitch Mc­Con­nell, R-Ky., fol­lows Re­id’s speeches on the floor. But Mc­Con­nell has yet to take a po­s­i­tion on Syr­ia. Sen. Dan Coats, R-Ind., spoke next and said the de­bate was only oc­cur­ring be­cause of Pres­id­ent Obama’s ill-ad­vised “red line” re­mark about chem­ic­al war­fare in Syr­ia.

“If the pres­id­ent had not drawn his red line, we would not be hav­ing this dis­cus­sion,” Coats said.

What We're Following See More »
Doesn’t Express Confidence in Marino
Trump to Declare Opioid Emergency Next Week
1 hours ago
THE LATEST

After initially promising it in August, "President Trump said Monday that he will declare a national emergency next week to address the opioid epidemic." When asked, he also "declined to express confidence in Rep. Tom Marino (R-Pa.), his nominee for drug czar, in the wake of revelations that the lawmaker helped steer legislation making it harder to act against giant drug companies."

Source:
INTERVIEW THIS WEEK
Trump Still Considering Yellen For Fed
9 hours ago
THE LATEST

"President Donald Trump plans to formally interview Janet Yellen this week about potentially staying on as Federal Reserve chair, two people familiar with the matter said...Many Republicans on Capitol Hill want Trump to move on from Yellen, whose first term ends in February, and choose a more traditionally conservative Fed chair."

Source:
NOMINEE FOR ONDCP
Trump Noncommittal on Marino
9 hours ago
THE DETAILS
IN LIGHT OF 60 MINUTES REVELATIONS
Manchin Asks Trump to Drop Marino’s Nomination for Drug Czar
10 hours ago
THE LATEST
WOULD OVERTURN MARINO LEGISLATION ON DRUG DISTRIBUTORS
McCaskill Will Introduce Bill in Response to “60 Minutes” Scoop
11 hours ago
THE DETAILS

In the wake of Sunday's blockbuster 60 Minutes/Washington Post report on opioid regulation and enforcement, Sen. Claire McCaskill (D-MO) has introduced legislation that "would repeal a 2016 law that hampered the Drug Enforcement Administration’s ability to regulate opioid distributors it suspects of misconduct." In a statement, McCaskill said: “Media reports indicate that this law has significantly affected the government’s ability to crack down on opioid distributors that are failing to meet their obligations and endangering our communities."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login